Cambridge Cognition inks multiple new contracts for virtual trials
27th May 2020 10:08
(Sharecast News) - Digital brain health products developer Cambridge Cognition has secured several new contracts to support pharmaceutical clients in delivering virtual clinical trials, including two contracts collectively worth over £1m.
Read moreCambridge Cognition losses widen amid sales slump
19th Feb 2020 08:03
(Sharecast News) - Digital solutions development group Cambridge Cognition warned on Wednesday that its full-year losses were set to widen after the lower level of sales seen throughout the first half of the year extended into the third quarter
Read moreCambridge Cognition gains client with improved electronic assessment platform
25th Nov 2019 09:36
(Sharecast News) - Brain health solutions developer Cambridge Cognition Holdings announced the launch of an improved electronic clinical outcomes assessment ('eCOA') platform on Monday, claiming it had already attracted a new client from one of the world's top 10 pharmaceutical companies.
Read moreCambridge Cognition hoping to ride coat-tails of Biogen Alzheimer's programme
25th Oct 2019 15:22
(Sharecast News) - Cambridge Cognition announced on Friday that, Following a consultation with the US Food and Drug Administration (FDA), Biogen and Eisai have announced plans to pursue regulatory approval for 'aducanumab', which would be the first therapy to tackle clinical decline in early Alzheimer's disease.
Read moreCambridge Cognition shares tumble after profit warning
27th Aug 2019 09:17
(Sharecast News) - Digital solutions developer Cambridge Cognition warned on Tuesday that interim losses looked set to widen after revenues dwindled and costs grew in the six months ended 30 June.
Read moreCambridge Cognition wins biggest digital health contract to date
19th Mar 2019 11:20
(Sharecast News) - Neuroscience technology company Cambridge Cognition Holdings announced a "significant" new contract on Tuesday, providing its digital health technologies to a major pharmaceutical company for application in a clinical stage development programme.
Read moreCambridge Cognition slips as low order intake sends loss deeper
7th Mar 2019 12:32
(Sharecast News) - Cambridge Cognition's shares slipped on Thursday after it reported that low order intake from 2017 had caused its annual losses to widen and revenues to fall.
Read moreCambridge Cognition soars on Indian software partnership
31st Jan 2019 13:28
(Sharecast News) - Cambridge Cognition leapt on Thursday after entering a partnership with a major pharmaceutical company to deliver online neurological testing to patients in India using its cloud-based CANTAB Connect platform.
Read moreCambridge Cognition shares tumble as revenues fall short of expectations
19th Dec 2018 08:52
(Sharecast News) - Neuroscience technology developer Cambridge Cognition has seen revenues fall short of expectations and losses widen as a result of a switch in accounting practices.
Read moreCambridge Cognition announces first NeuroVocalix commercial partnership
19th Sep 2018 10:14
(Sharecast News) - Neuroscience technology company Cambridge Cognition Holdings announced its first commercial partnership for its recently launched 'NeuroVocalix' voice biomarker technology on Wednesday.
Read moreCambridge Cognition gains US regulatory approval for memory test
25th Jan 2017 08:27
(ShareCast News) - Neuroscience digital health company Cambridge Cognition has gained regulatory clearance for its memory test to be used as a medical device in the US. Cantab Mobile, which detects clinically-relevant memory impairment in older adults at the point of care, received 510k clearance fo
Read moreCambridge Cognition confirms series of new contracts
13th Oct 2016 10:55
(ShareCast News) - Neuroscience company Cambridge Cognition Holdings announced a series of new contracts worth more than £0.25m on Thursday, to assess - through CANTAB Connect - the abuse potential of investigational drugs in a new market application for the company. The AIM-traded firm claimed that
Read moreCambridge Cognition's sales up after investments in marketing
22nd Sep 2016 10:23
(ShareCast News) - Cambridge Cognition' half-year revenues grew and losses were more than halved as the neuroscience software and hardware company's invested in marketing and development. For the six months ended 30 June, revenue increased by 11.3% to £3.26, compared to the same period last year. T
Read moreCambridge Cognition announces promising results from technology study
16th Aug 2016 13:49
(ShareCast News) - Neuroscience company Cambridge Cognition Holdings announced results on Tuesday from a new technology feasibility study. The AIM-traded firm, which develops and markets near-patient technologies for the assessment of brain health to improve the drug development process, said the re
Read moreCambridge Cognition signs distribution deal with Manus Neurodynamica
22nd Jun 2016 09:50
(ShareCast News) - AIM-listed neuroscience technology company Cambridge Cognition Holdings has signed a distribution agreement to market a Parkinson's sensor pen for healthcare technology group Manus Neurodynamica. Manus' sensor pen is used for the diagnosis and monitoring of neuromotor impairments
Read more